Validations: Serialization, Aggregation & Supply-Chain Data Integrity
Traceability into WMS/TMS: Handshakes That Work Traceability into WMS/TMS: Handshakes That Work Introduction to Traceability in Serialization and Aggregation In the current climate of stringent regulatory demands, ensuring proper traceability throughout the pharmaceutical supply chain is paramount. With initiatives such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medicines Directive (FMD) in…
Inbound Aggregation from CMOs: Parity and Exceptions Inbound Aggregation from CMOs: Parity and Exceptions Introduction to Inbound Aggregation in Pharmaceutical Manufacturing The pharmaceutical industry faces continuous pressure to ensure product integrity and compliance throughout its supply chain. One critical aspect of this is inbound aggregation from Contract Manufacturing Organizations (CMOs). This process directly impacts serialization and drug supply chain integrity,…
Mock Loads: Performance and Throughput Testing Mock Loads: Performance and Throughput Testing The pharmaceutical industry is inherently complex, with the regulatory landscape continuously evolving. One crucial aspect of this complexity is the need for effective validation of serialization and aggregation processes. In this tutorial, we will explore a detailed approach to conducting mock loads for performance and throughput testing, focusing…
Label Symbologies & Print Quality: ISO/IEC Hooks Label Symbologies & Print Quality: Utilizing ISO/IEC Hooks in Pharma Validation Understanding the Importance of URS in Serialization and Aggregation In the pharmaceutical industry, the validation of serialization and aggregation processes is critical to ensuring compliance with regulatory requirements such as the Drug Supply Chain Security Act (DSCSA) in the United States, the…
Master Data Change Management in Pharmaceutical Validation Introduction to Master Data Change Management Master Data Change Management (MDCM) serves as a critical foundation for effective serialization and aggregation within pharmaceutical supply chains. This article provides a detailed guide on managing changes in master data, focusing on the User Requirements Specifications (URS), interface validation, and the underlying principles that ensure data…
Data Retention & Privacy: What Must Be Kept The landscape of pharmaceutical validation and compliance is continually evolving, particularly with respect to data retention and privacy. The increasing scrutiny by regulatory bodies such as the FDA, EMA, and MHRA emphasizes the importance of maintaining accurate and accessible data throughout the manufacturing and distribution processes. This article will serve as a…
Disaster Recovery for Serialization Systems Disaster Recovery for Serialization Systems In today’s pharmaceutical landscape, ensuring the reliability of serialization systems is paramount for compliance with regulatory frameworks such as the FDA’s Drug Supply Chain Security Act (DSCSA), the EU Falsified Medicines Directive (FMD), and various other global standards. This article serves as a comprehensive, step-by-step tutorial guide for pharmaceutical professionals…
Clock Sync & Time Zones: Event Ordering Clock Sync & Time Zones: Event Ordering in Serialization Systems Introduction to Event Ordering in Serialization The pharmaceutical industry faces stringent regulatory requirements for serialization and aggregation to ensure drug traceability and safety. Regulatory bodies such as the FDA, EMA, and MHRA emphasize the importance of master data governance in managing serialization workflows….
Partner Connectivity: Gateways, Certificates, and SLAs Partner Connectivity: Gateways, Certificates, and SLAs In the pharmaceutical industry, ensuring compliance with Serialization and Aggregation standards is paramount for enhancing supply chain integrity and data quality. The objective of this step-by-step tutorial is to provide a comprehensive guide on Partner Connectivity, focusing on Gateways, Certificates, and Service Level Agreements (SLAs). This content will…
TDP/Blueprints for Multi-Market Programs (US/EU/BR/IN) TDP/Blueprints for Multi-Market Programs (US/EU/BR/IN) Introduction to Multi-Market Serialization and Aggregation The advent of serialization and aggregation mandates such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medications Directive (EU FMD) has forged a new landscape for pharmaceutical companies engaged in multiple market operations. Regulatory requirements necessitate…